# FDA Inspection 1155166 - Kite Pharma, Inc. - October 22, 2021

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/04652416-8b0d-4877-a0bd-dffeb9a087b1
Source feed: FDA_Inspections

> FDA Inspection 1155166 for Kite Pharma, Inc. on October 22, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155166
- Company Name: Kite Pharma, Inc.
- Inspection Date: 2021-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279894 - 2025-08-27](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/6c854143-66e4-4bfa-b0da-a4e4e9b83d60)
- [FDA Inspection 1155166 - 2021-10-22](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/aef1fdf4-fcc5-44c8-ba94-e905a18663db)
- [FDA Inspection 1100058 - 2019-08-20](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/76901832-4400-44b6-9915-b8aa6c598211)

Company: https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d